isoborneol has been researched along with Brain Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, L; Duanmu, W; Feng, H; Gao, F; Ge, H; Hu, R; Li, F; Tan, L; Tunan, C; Yin, Y; Yuan, J | 1 |
Chen, L; Guo, X; Wang, H; Wu, G | 1 |
Chen, L; Chu, X; Gao, Z; Guan, Y; Huang, W; Jin, M; Liu, X; Meng, L; Xin, X; Xing, H | 1 |
Fang, L; Han, S; Li, F; Li, J; Liang, Z; Sun, Y; Tao, C; Xu, X; Zhu, J | 1 |
Chen, H; Duan, M; Guo, J; Xing, Y; Zhang, R | 1 |
5 other study(ies) available for isoborneol and Brain Neoplasms
Article | Year |
---|---|
L-Borneol induces transient opening of the blood-brain barrier and enhances the therapeutic effect of cisplatin.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Camphanes; Capillary Permeability; Cisplatin; Claudin-5; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Glioma; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Nervous System Diseases; Occludin; Platinum | 2017 |
Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain; Brain Neoplasms; Camphanes; Carmustine; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Endothelial Cells; Glioma; Humans; Mice; Mice, Nude; Micelles; Nanomedicine; Nanoparticles; Xenograft Model Antitumor Assays | 2019 |
Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
Topics: Animals; Antibiotics, Antineoplastic; Blood-Brain Barrier; Brain Neoplasms; Camphanes; Cell Line; Cell Survival; Doxorubicin; Drug Liberation; Glioblastoma; Humans; Male; Mice, Inbred ICR; Micelles; Nanostructures; Rats; Wound Healing | 2019 |
A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Camphanes; Cell Line; Dendrimers; Doxorubicin; Endothelial Cells; Folic Acid; Glioma; Humans; Molecular Structure; Neoplasms, Experimental; Neuroglia; Rats; Rats, Wistar; Tissue Distribution | 2016 |
Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Camphanes; Capillary Permeability; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glioma; Male; Rats; Rats, Sprague-Dawley; Tight Junction Proteins; Tight Junctions | 2016 |